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PAROTID TUMOURS
By MILLAR BELL and JOHN J. O'NEILL
Belfast City Hospital
TUMOURS of the salivary glands are relatively uncommon. From 1958 through
1968 a total of 77 lesions of all the salivary glands were seen by one of us (M.B.)
and 67 involved the parotid, 8 the submaxillary, one the sublingual and one an
ectopic gland. In this paper we present our experience with the 'partoid' lesions,
which comprise the largest group in the series, 67 out of a total of 77, as enumer-
ated in Table I.
CLINICAL FEATURES
The classical and frequently the only symptom and sign of a parotid tumour is
a swelling. Only occasionally is slight pain or discomfort noted. Very often there
is a long delay from the time the swelling is first noticed until the patient is
referred to hospital, and in this series it varied from six weeks to 38 years.
Of the 7 patients with carcinoma of the parotid, 5 had local pain. Some degree
of facial paresis is often mentioned as an early sign, but in this series 5 out of 7
cases had no facial paresis when first seen. So far as could be ascertained, 4 patients
had no pre-existing tumour, while in the remaining three there had been a pre-
existing tumour, presumably benign, for several years. In one instance a tumour
had been present for about 30 years, but two months before referral to hospital it
began to increase in size, the patient developed pain and there was weakness of
the facial nerve.
DIFFICULTY IN DIAGNOSIS
Accurate pre-operative diagnosis of a swelling in the parotid gland is difficult.
Patey (1968) quoted Bland Sutton, who said that swellings in the parotid were
"interesting lumps that required removal." In some cases the history is helpful,
and in a few the diagnosis is comparatively easy. Of the lesions listed in Table I,
acute non-purulent parotitis, chronic parotitis and calculus are fairly readily
diagnosed. Also cystic hygroma and branchial cyst should be suspected from the
clinical features. In all the other lesions seen diagnosis was not possible from the
TABLE I - Parotid Tumours - 617
Cystic Hygroma 1 Acute (non-purulent parotitis 2
Bronchial Cyst 2 Chronic Parotitis 16
Lipoma 4 Calculus 2
Boeck's Sarcoidosis 1 Mixed Salivary Tumours 24
Hodgkin's 1 Adenoma 2
Sec. Carcinoma 1 Adeno-Lymphoma 2
Carcinoma 7
Carcoma 2
48history and clinical examination, with the possible exception of the one case of
secondary carcinoma. The frequency of wrong clinical diagnosis is high and in a
study carried out some years ago it amounted to 40 per cent (Patey and Hand,
1952).
Sialography has not been found of any help in diagnosis. The question there-
fore of biopsy has to be considered. It is well known that mixed salivary tumours
(pleomorphic salivary adenoma) have a very thin capsule which is easily ruptured
with resultant spillage of tumour cells into adjacent normal tissue. This can result
in the production of multiple tumours in the parotid, or indeed, in the overlying
skin. The danger of implantation is less with needle biopsy but has occurred
(Eneroth, 1964). Interpretation of such limited material is difficult on histological
examination.
Wide excisional biopsy is therefore necessary. That is, removing a wide margin
of normal tissue with the tumour. This raises special problems in tumours of the
parotid because of the intimate relationship of the trunk and branches of the facial
nerve to the parotid. Excisional biopsy therefore involves exposure of the trunk of
the facial nerve and subsequent identification of its main and subsidiary branches.
At least 90 per cent of tumours of the parotid gland arise in the superficial lobe
and therefore excisional biopsy essentially means superficial parotidectomy. There
should be no resultant paresis of the facial nerve.
TREATMENT
The main principles of treatment of tumours of the parotid gland can be summed
up as - wide surgical exposure by a cervico-facial (Y-shaped incision), early identi-
fication of the trunk of the facial nerve and removal of the tumour together with
such surrounding tissues as the pathology demands (Patey, 1966).
It is generally agreed that it is better in the majority to expose the facial nerve
as it emerges from the stylomastoid foramen than to trace back one of its branches
from the anterior border of the parotid. This latter method results in a high
incidence of residual permanent paralysis of the facial nerve. The nerve runs
outwards and forwards from the stylomastoid foramen and at the isthmus of the
parotid gland divides into two main branches which subsequently divide into the
terminal branches of the nerve (pes anserinus). Removal of the gland superficial
to the facial nerve is known as superficial parotidectomy. Removal of the whole of
the parotid, sparing the facial nerve is termed total parotidectomy. Radical parotid-
ectomy means total parotidectomy with sacrifice of the facial nerve.
The importance of the venous plexus lying immediately deep to the facial nerve
has been emphasised (Patey and Ranger, 1957). Troublesome venous bleeding can
occur from one of these small veins and anaesthesia with induced hypotension has
been found to be of help in what can sometimes be a difficult dissection, particul-
arly in cases of chronic parotitis.
Local excision of a small peripheral tumour is possible because, in such a
situation the tumour can be excised with a margin of normal parotid tissue without
the risk of significant damage to the facial nerve. In treating malignant tumours,
radical parotidectomy is necessary in the majority of cases. In a very small lesion
it may be possible to preserve one of the main divisions of the facial nerve. Where
there is involvement of lymph glands in the neck block dissection is indicated with
49radical parotidectomy. Most malignant tumours are not sensitive to radiation but
it has been employed following one or two difficult dissections where it was
considered that there was spillage of the tumour during operation. The various
methods of treatment are indicated in Table II, and more specific reference will
be made to pre-operative regional intra-arterial infusion.
TABLE II - Method of Treatment
Benign Tumours (a) Superfacial Parotidectomy
? ? Local Excision
(b) Total Parotidectomy
MalignantTumours (a) Radical Parotidectomy
(b) Parotidectomy with partial preservation of facial
nerve
(c) Radical Parotidectomy and Block Dissection
(d) Pre-operative regional intra-arterial infusion and
radical parotidectomy
(e) Radical Parotidectomy and Deep X-ray Therapy
Mixed Parotid Tumours (Pleomorphic Salivary Adenomas)
In the series superfacial parotidectomy was performed in 16 cases. Total parotid-
ectomy with conservation of the facial nerve was carried out in one case. This was
necessary because the tumour involved the deep part of the gland. Local excision
was performed in 3 cases. In 4 cases the tumour was recurrent following operation
elsewhere. The recurrences were 1 year, 4 years, 16 years and 33 years respectively
after the primary operation. Three of these were treated by superficial parotid-
ectomy and one by local incision.
In the series radiotherapy was given post-operatively in two cases where spillage
occurred during the operation.
Malignant lesions of the Parotid
There were 7 cases of carcinoma and two cases of sarcoma, as detailed in Table
III. In the carcinoma group, two cases with mucoepidermoid tumours were seen
at a comparatively late stage when they had involvement of glands in the neck,
and were treated by radical parotidectomy with ipsilateral block dissection of the
cervical glands. Likewise, one patient with an acinic cell tumour required radical
TABLE III - Malignant Group
Carcinoma Sarcoma
Mucoepidermoid 2 Reticulum Cell 1
Acini Cell 1 Myosarcoma 1
Squamous 2
Adenocarcinoma 1
Undifferentiated 1
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the cases had post-operative radiotherapy. Of the two cases of squamous carcinoma,
one had a very small tumour and was treated by superfacial parotidectomy, the
other case had had a biopsy done elsewhere and the tumour seemed to be growing
very rapidly, with a very marked inflammatory reaction, so that surgical treatment
was not considered possible. We had recently treated an elderly patient with an
inoperable recurrent squamous carcinoma of cheek by regional intra-arterial retro-
grade infusion of methotraxate via the superfacial temporal artery, and were
greatly encouraged by an initial dramatic response. Although this was not main-
tained it did encourage us to try the same treatment, in this case of carcinoma of
the parotid. There was a most encouraging response as evidenced by regression in
size of the tumour and disappearance of all the inflammatory reaction, at which
stage we proceeded to do a parotidectomy. This patient did not have facial paresis
pre-operatively but at operation it was found impossible to preserve the trunk and
upper branches of the facial nerve. The case of undifferentiated carcinoma was
treated by superficial parotidectomy in the first instance, because the tumour was
small and there was no involvement of the facial nerve. Subsequently, when we
received the histological report this patient was referred for post-operative radio-
therapy.
There were two cases of sarcoma of the parotid, the case of reticulum cell
sarcoma had a small tumour and was treated as though he had a pleomorphic
salivary adenoma. When the histo-pathology was subsequently revealed he was
referred to for post-operative x-ray therapy. The case of myosarcoma had had one
or two biopsies done elsewhere and had a most extensive tumour with involvement
of the cervical glands on the affected side. He was treated by radical parotidectomy
and ipsilateral block dissection of the cervical glands.
COMPLICATIONS
Complications are not frequently encountered and are as detailed in Table IV.
Infection has been noted in several cases but has never been severe or persistent,
with one exception, a case of intractable chronic parotitis. The patient inexplicably
developed thrombosis in the vessels in the lobe of his ear which subsequently
proceeded to a state of dry gangrene and separated.
TABLE IV - Complications of Operation
Infection Mild in four cases
Haematoma Two cases
Sensory loss In lobe of ear in all cases
Facial paresis Partial and temporary in 8 cases
Total and permanent in 3 cases.
Total and permanent in 3 cases of carcin-
oma and one case of sarcoma
Residual weakness in 2 cases of recurrent
mixed salivary tumour
Auriculo-temporal syndrome 2 cases
Parotid Fistula None
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auricular nerve going to the lobe of the ear, and thus there is a loss of sensation
in the lobe of the ear in all cases. Patey states that it is possible to preserve these
branches in some cases but to date it has not been found possible by us. The loss
of sensation in the lobe of the ear has been commented upon by many of the
patients, but has not otherwise been a problem.
Regarding facial paresis, the importance of identification of the trunk and
branches of the facial nerve must be stressed. It will be noted that in three cases
there was temporary and total facial paralysis, but when the operator has seen
the facial nerve, he can with confidence reassure the patient and, in our three
cases, there was subsequent complete restoration of function. The interval was
1 month, 2 months and 3 months respectively. The branch of the facial nerve which
is most often involved is perhaps the longest branch, that is, the one supplying the
angle of the mouth and the lower lip. Paresis involving this branch of the nerve
has only persisted in two cases who had recurrent mixed salivary tumours.
The auriculo-temporal syndrome did appear in two cases, and it is interesting
to note that in one case it did not appear for approximately one year following
superfacial parotidectomy, and in the other, several months after operation. It has
not been severe in either case and in the first case it has clear up almost completely.
RESULTS
All cases have had complete follow-up to date. Table V summarises the results
in the mixed parotid and recurrent mixed parotid tumours. Table VI shows the
TABLE V - Mixed Tumours
Follow-up in years
Type No. of cases 1 4 8
Primary 20 10 4 1
Recurrent 4 3 1
Total 24 13 5 1
There have been no recurrences in the follow-up periods.
TABLE VI - Carcinoma
Follow-up inyears
Type No. of cases 6/12 1 year 2years
Squamous 2 (1) - (1)*
Adenocarcinoma 1 (1)
Undifferentiated 1 - 1
Mucoepidermoid 2 (2)
Acinic Cell 1 - - 1
Parenthesis show recurrences and death from metastasis.
*Died at 2 years from heart attack - no evidence of disease.
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cases with adenolymphoma show no evidence of recurrence 7j years and nine
months post-operatively.
DISCUSSION
Tumours of the parotid are uncommon and as has been pointed out accurate
pre-operative diagnosis as to the nature of the pathology is difficult. With the
wider acceptance of the principles of parotid surgery treatment is becoming more
standardised. For mixed tumours superfacial parotidectomy is the treatment of
choice. Radiotherapy has little or no effect on the primary tumour but can be used
post-operatively where spillage has occurred in an attempt to destroy microscopic
tumour deposits. Evidence for this is that in the past, when surgical treatment was
more conservative and tumours were simply shelled out, the implantation of radium
was found to reduce the incidence of recurrence (Ahlbom, 1935).
Van Meirt, Dawes and Harkness (1968) recommended simple enucleation followed
by radiotherapy in the treatment for mixed parotid tumours. Over a period of
twenty-six years a total of 167 patients were treated by enucleation and radiotherapy
and recurrence rate was stated to be 2.74 per cent, but this method of treatment
is not generally accepted.
Follow up of these cases has to be long as late recurrence is a characteristic
(Patey, 1967). Recurrent mixed tumours are more difficult to treat because although
clinically they may appear to be a single nodule, there is often widespread diffusion
of tumour in the operation area. rhe risk of damage to the facial nerve is greater
and in the present series two cases have residual weakness of the lower part of the
facial nerve.
In most series the percentage of tumours classified as malignant is in the order
of 15 to 25 per cent (Patey et al, 1965; Eneroth, 1964; Sharp and Helsper, 1960),
but an incidence of 34 per cent was reported by Foote and Frazell (1954). In the
present series it was 16.3 per cent. The results of treatment of carcinoma are bad,
most patients dying of the disease irrespective of the treatment given. One case
in this series who had an inoperable squamous carcinoma when first seen and to
which reference has already been made (vide supra) had a dramatic response to
regional intra-arterial retrograde infusion of methrotraxate. This produced a
situation in which surgery was possible, and the patient lived for two years and
died from a heart attack.
Chemotherapy in the treatment of malignant disease has most often been used
for late cases when other methods of treatment have failed. The head and neck
is one area where regional infusion is anatomically feasible, and while one cannot
draw conclusions from encouragement in one case it does, nevertheless, suggest
that pre-operative infusion of a chemotherapeutic agent should be tried in an area
where our present methods of treatment give unsatisfactory results.
SUMMARY
All cases of parotid tumours occurring over a ten year period are reviewed with
particular reference to clinical features, difficulty in diagnoses, treatment, compli-
cations and results.
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BOOK REVIEW
SOME INHERITED DISORDERS OF BRAIN AND MUSCLE. Edited by J. D.
Allan and D. N. Raine. (Pp. viii+ 154; figs. 53. 40s). Edinburgh and London:
E. & S. Livingstone, 1969.
THIS volume is the published proceedings of the fifth symposium of the Society for the Study
of Inborn Errors of Metabolism held in Newcastle in 1968. Previous symposia in this series
have been valuable collections of papers in a rapidly expanding, multi-disciplinary field and
this volume is no exception. Walton's discussion of the classification of muscular dystrophy
is a fair summary of a difficult subject. Some of the papers are of specialist interest e.g.
McArdle's on skeletal muscle glycogenosis, but because of the combined clinical and bio-
chemical discussion even these are of general importance. The cerebral lipidoses feature
prominently in the papers on disorders of brain metalolism, presumably because other abnor-
malities have been discussed in previous symposia, but Walshe's combined genetic and bio-
chemical study in Wilson's disease helps to balance this part of the back.
Obviously this volume has a restricted appeal but it contains information of great interest
to many medical specialists and can be recommended to the biochemist, the morbid anatomist
and the paediatric neurologist. To those contemplating postgraduate, examinations it provides
valuable information on some of the rare disorders which seem to interest some examiners.
I.V.A.
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